Pulmonary and peritoneal tuberculosis in a CAPD patient.
Patients with chronic renal failure have an increased incidence of tuberculosis due to decreased cellular immunity. More than half of the tuberculosis infection in these patients presented with extrapulmonary involvement. Tuberculous peritonitis is an important problem in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Simultaneous pulmonary and peritoneal tuberculosis is a very rare condition. We describe a 39-year-old man with culture negative CAPD peritonitis. In spite of conventional antimicrobial therapy the patient had persistent fever, weight loss, and night sweats. Approximately after one month from starting treatment, both sputum specimen and peritoneal fluid were positive for mycobacterium. Quadruple therapy for tuberculosis has been started. The response to treatment was promptly. He is still on treatment for six months and receiving CAPD. Tuberculous peritonitis should always be considered when patients on CAPD develop culture negative peritonitis treated with conventional antibiotics without improvement. In addition, the existence of extraperitoneal tuberculosis, especially pulmonary disease must be investigated.
Canbakan
Basol
B
Department of Nephrology, Ibni Sina Hospital, Ankara University School of Medicine, Sihhiye, Ankara, 06100, Turkey.
Ergun
Ihsan
I
Ekmekci
Yakup
Y
Ates
Kenan
K
Karatan
Oktay
O
D000328:Adult; D000995:Antitubercular Agents / Q000627:therapeutic use; D002114:Calcinosis / Q000000981:diagnostic imaging; D006801:Humans; D008198:Lymph Nodes / Q000000981:diagnostic imaging / Q000473:pathology; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D014395:Peritonitis, Tuberculous / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D011859:Radiography; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*
D000995:Antitubercular Agents